299 related articles for article (PubMed ID: 24697923)
1. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.
Zimmermann GS; von Wulffen W; Huppmann P; Meis T; Ihle F; Geiseler J; Leuchte HH; Tufman A; Behr J; Neurohr C
Respirology; 2014 Jul; 19(5):700-6. PubMed ID: 24697923
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension.
Shapiro S; Traiger G; Hill W; Zhang L; Doran AK
Cardiovasc Ther; 2013 Oct; 31(5):274-9. PubMed ID: 23841794
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of sildenafil in interstitial pneumonia with pulmonary hypertension].
Watanabe N; Taniguchi H; Kondoh Y; Kimura T; Kataoka K
Nihon Kokyuki Gakkai Zasshi; 2011 Mar; 49(3):151-5. PubMed ID: 21485145
[TBL] [Abstract][Full Text] [Related]
4. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ
Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.
Wang L; Zhao QH; Pudasaini B; Jiang R; Gong SG; He J; Yuan P; Liu JM
Clin Respir J; 2018 Mar; 12(3):915-921. PubMed ID: 28026153
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
Mittoo S; Jacob T; Craig A; Bshouty Z
Can Respir J; 2010; 17(6):282-6. PubMed ID: 21165350
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil improves hemodynamic parameters in COPD--an investigation of six patients.
Alp S; Skrygan M; Schmidt WE; Bastian A
Pulm Pharmacol Ther; 2006; 19(6):386-90. PubMed ID: 16291503
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
[TBL] [Abstract][Full Text] [Related]
10. Safety and long-term efficacy of transition from sildenafil to tadalafil due to side effects in patients with pulmonary arterial hypertension.
Lichtblau M; Harzheim D; Ehlken N; Marra A; Pinado FP; Grünig E; Egenlauf B
Lung; 2015 Feb; 193(1):105-12. PubMed ID: 25318865
[TBL] [Abstract][Full Text] [Related]
11. Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.
Wu X; Yang T; Zhou Q; Li S; Huang L
Eur J Heart Fail; 2014 Apr; 16(4):444-53. PubMed ID: 24464734
[TBL] [Abstract][Full Text] [Related]
12. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
13. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
[TBL] [Abstract][Full Text] [Related]
14. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
15. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
19. Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial.
Hoeper MM; Halank M; Wilkens H; Günther A; Weimann G; Gebert I; Leuchte HH; Behr J
Eur Respir J; 2013 Apr; 41(4):853-60. PubMed ID: 22936711
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary artery hypertension in heart transplant recipients: how much is too much?
De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C
Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
